AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Q/C TECHNOLOGIES, INC. Director's Dealing 2014

Jan 24, 2014

35313_dirs_2014-01-24_c1e5716a-3aff-4d44-a204-13444c55994d.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Akers Biosciences Inc (AKER)
CIK: 0001321834
Period of Report: 2014-01-23

Reporting Person: Knox Thomas J (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, no par value	358150	Direct